The scope for patenting stem cell-based inventions in Europe was dealt a blow by the judgement of the CJEU in Brüstle vs Greenpeace (C 34/10)1. The practical result of this judgement was that the earliest date from which the EPO would acknowledge that morally...
Biopiracy is the evil sibling of bioprospecting. Bioprospecting is the search for existing genetic resources and biological knowledge that can be applied more widely and in novel applications. This is an area of particular interest to the pharmaceutical industry...
Therefore, applicants may wish to consider filing any available complete applications and national phase entry applications in New Zealand prior to 13 September 2014 in order to not only avoid the more stringent patentability requirements of the New Act but also to...
Selected points of interest are as follows: New regulations to streamline and clarify existing procedures. This is done through detailing e filing provisions, introducing the “division of trade mark applications” for partially refused applications,...
Consequently, it has long been desired to have a European patent with unitary effect, that is, a patent application that is searched and examined by the EPO but which upon grant is automatically in force in all EU member states. Progress towards such a unitary patent...
Recent Comments